CSLI yields 2000000.00% · PFE yields 6.20%● Live data
📍 CSLI pulled ahead of the other in Year 1
Combined, CSLI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSLI + PFE for your $10,000?
Critical Solutions, Inc., through its subsidiary, White Door, Inc., manufactures and sells alternate powered systems in the United States. The company's alternate powered systems utilize solar panels, wind turbines, and hydrogen fuel cells to power physical security and communication requirements for areas where power is difficult to obtain, or where conventional power means are expensive to deploy. Its products are used by defense contractors to secure nuclear power plants, by the Federal Bureau of Prisons for emergency response teams, and the U.S. airports for emergency communication and ground surveillance. The company was incorporated in 2008 and is headquartered in Ashburn, Virginia. On June 4, 2013, an involuntary petition for liquidation under Chapter 7 was filed against Critical Solutions, Inc., in the U.S. Bankruptcy Court for the Eastern District of Virginia. July 1, 2013, the involuntary petition was approved by the Court. Critical Solutions, Inc. is in liquidation.
Full CSLI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.